{
    "doi": "https://doi.org/10.1182/blood.V114.22.4825.4825",
    "start_url": "https://ashpublications.org/blood/search-results?sort=Date+-+Oldest+First&f_ArticleTypeDisplayName=Meeting+Report&fl_SiteID=1000001&page=1496",
    "start_url_page_num": 1496,
    "is_scraped": "1",
    "article_title": "Aspirin Induces Apoptosis in Human Leukemia Cells Independently of NF-\u03baB and MAPKs through Alteration of the Mcl-1/Noxa Balance. ",
    "article_date": "November 20, 2009",
    "session_type": "MOLECULAR PHARMACOLOGY, DRUG RESISTANCE",
    "topics": [
        "apoptosis",
        "aspirin",
        "leukemia",
        "phosphotransferases",
        "anti-inflammatory agents",
        "anti-inflammatory agents, non-steroidal",
        "chronic b-cell leukemias",
        "chronic lymphocytic leukemia",
        "mitogen-activated protein kinase p38",
        "rna, messenger"
    ],
    "author_names": [
        "Ana M Cosialls",
        "Daniel Iglesias-Serret, PhD",
        "Maria Pique\u0301, PhD",
        "Montserrat Barraga\u0301n, PhD",
        "Antonio F Santidria\u0301n, PhD",
        "Diana M Gonza\u0301lez-Girone\u0300s",
        "Llorenc\u0327 Coll-Mulet, PhD",
        "Merce\u0300 de Frias",
        "Alberto Fernandez de Sevilla, MD, PhD",
        "Gabriel Pons, MD, PhD",
        "Joan Gil, PhD"
    ],
    "author_affiliations": [
        [
            "Ciencies Fisiologiques II, IDIBELL-Universitat de Barcelona, L'Hospitalet de Llobregat, Spain, "
        ],
        [
            "Ciencies Fisiologiques II, IDIBELL-Universitat de Barcelona, L'Hospitalet de Llobregat, Spain, "
        ],
        [
            "Programa d'Expressio\u0301 Ge\u0300nica, Centre de Regulacio\u0301 Geno\u0300mica, Barcelona, Spain, "
        ],
        [
            "Ciencies Fisiologiques II, IDIBELL-Universitat de Barcelona, L'Hospitalet de Llobregat, Spain, "
        ],
        [
            "Ciencies Fisiologiques II, IDIBELL-Universitat de Barcelona, L'Hospitalet de Llobregat, Spain, "
        ],
        [
            "Ciencies Fisiologiques II, IDIBELL-Universitat de Barcelona, L'Hospitalet de Llobregat, Spain, "
        ],
        [
            "Ciencies Fisiologiques II, IDIBELL-Universitat de Barcelona, L'Hospitalet de Llobregat, Spain, "
        ],
        [
            "Ciencies Fisiologiques II, IDIBELL-Universitat de Barcelona, L'Hospitalet de Llobregat, Spain, "
        ],
        [
            "Hematologia Clinica, Institut Catala D'Oncologia, Barcelona, Spain"
        ],
        [
            "Ciencies Fisiologiques II, IDIBELL-Universitat de Barcelona, L'Hospitalet de Llobregat, Spain, "
        ],
        [
            "Ciencies Fisiologiques II, IDIBELL-Universitat de Barcelona, L'Hospitalet de Llobregat, Spain, "
        ]
    ],
    "first_author_latitude": "41.3867751",
    "first_author_longitude": "2.1637277999999998",
    "abstract_text": "Abstract 4825 Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) induce apoptosis in most cell types. We examined the mechanism of aspirin-induced apoptosis in human leukemia cells. Our results show that aspirin induced apoptosis in leukemia Jurkat T cells independently of NF-\u03baB. Although aspirin induced p38 MAPK and c-Jun N-terminal kinase (JNK) activation, selective inhibitors of these kinases did not inhibit aspirin-induced apoptosis. We studied the regulation of Bcl-2 family members in aspirin-induced apoptosis. The mRNA levels of some pro-apoptotic members, such as BIM , NOXA , BMF or PUMA , were induced by aspirin. However, none of these pro-apoptotic proteins increased and the levels of Mcl-1 protein were reduced. Interestingly, in the presence of aspirin the protein levels of Noxa remained high. This alteration of the Mcl-1/Noxa balance was also found in other leukemia cell lines and primary chronic lymphocytic leukemia cells (CLL). Furthermore, in CLL cells aspirin induced an increase in the protein levels of Noxa. Knockdown of Noxa or Puma significantly attenuated aspirin-induced apoptosis. These results indicate that aspirin induces apoptosis through alteration of the Mcl-1/Noxa balance. Disclosures No relevant conflicts of interest to declare."
}